|
FY2025
12 months to Oct 31, 2025
|
FY2024
12 months to Oct 31, 2024
|
FY2023
12 months to Oct 31, 2023
|
FY2022
12 months to Oct 31, 2022
|
FY2021
12 months to Oct 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Selling, general and administrative | |||||
| Research and development costs | |||||
| Amortization of intangible assets | |||||
| Restructuring | |||||
| Impairment charges | |||||
| Total operating expenses | |||||
| Operating income | |||||
| Interest expense, net | |||||
| Loss (Gain) on sale of business | |||||
| Loss on investment in China JV | |||||
| Other expense | |||||
| Income before provision for income taxes | |||||
| Provision for income taxes | |||||
| Net income | |||||
| Other comprehensive loss, net of tax | |||||
| Comprehensive income | |||||
| Net income per common share: | |||||
| Basic | |||||
| Diluted | |||||
| Dividends declared per common share | |||||
Loading...